Follow
Chibuzor olelewe
Title
Cited by
Cited by
Year
Next generation gold drugs and probes: chemistry and biomedical applications
RT Mertens, S Gukathasan, AS Arojojoye, C Olelewe, SG Awuah
Chemical Reviews 123 (10), 6612-6667, 2023
352023
Mitochondria as a target of third row transition metal-based anticancer complexes
C Olelewe, SG Awuah
Current Opinion in Chemical Biology 72, 102235, 2023
182023
Gold (III)-P-chirogenic complex induces mitochondrial dysfunction in triple-negative breast cancer
C Olelewe, JH Kim, S Ofori, RT Mertens, S Gukathasan, SG Awuah
Iscience 25 (5), 2022
132022
The anti-breast cancer stem cell properties of gold (I)-non-steroidal anti-inflammatory drug complexes
A Johnson, C Olelewe, JH Kim, J Northcote-Smith, RT Mertens, G Passeri, ...
Chemical Science 14 (3), 557-565, 2023
112023
Chiral gold (III) complexes: speciation, in vitro, and in vivo anticancer profile
AS Arojojoye, JH Kim, C Olelewe, S Parkin, SG Awuah
Chemical Communications 58 (73), 10237-10240, 2022
72022
Serum-Stable Gold (III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer
AS Arojojoye, C Olelewe, S Gukathasan, JH Kim, H Vekaria, S Parkin, ...
Journal of Medicinal Chemistry 66 (12), 7868-7879, 2023
32023
Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer
MAO Afrifa, JH Kim, KA Pitton, C Olelewe, AS Arojojoye, DR Strachan, ...
ACS Applied Bio Materials 7 (3), 2012-2022, 2024
2024
A Breast Cancer Stem Active Cobalt (III)‐Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential
J Fang, ON Orobator, C Olelewe, G Passeri, K Singh, SG Awuah, ...
Angewandte Chemie International Edition 63 (6), e202317940, 2024
2024
A gold-based inhibitor of oxidative phosphorylation is effective against triple negative breast cancer
RT Mertens, JH Kim, S Ofori, C Olelewe, PJ Kamitsuka, GF Kwakye, ...
Biomedicine & Pharmacotherapy 170, 116010, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–9